Publications by authors named "Athena Countouriotis"

Claim this Profile
B
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, Francois Guilhot, Ladan Duvillié, Athena M Countouriotis

Br J Haematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
Jorge E Cortes, Dong-Wook Kim, Hagop M Kantarjian, Tim H Brümmendorf, Irina Dyagil, Athena M Countouriotis

J Clin Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.
H Jean Khoury, Jorge E Cortes, Hagop M Kantarjian, Carlo Gambacorti-Passerini, Michele Baccarani, Athena Countouriotis

Blood· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.
Hagop Kantarjian, Ricardo Pasquini, Nelson Hamerschlak, Philippe Rousselot, Jerzy Holowiecki, Athena Countouriotis

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.
Andreas Hochhaus, Hagop M Kantarjian, Michele Baccarani, Jeffrey H Lipton, Jane F Apperley, Athena M Countouriotis

Blood· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of bone marrow aspirates and biopsies in pediatric patients with ALL at days 7 and 14 of induction therapy.
Athena Countouriotis, Elliot M Landaw, Faramarz Naeim, Theodore B Moore, Kathleen M Sakamoto

Leuk Lymphoma· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional regulators and myelopoiesis: the role of serum response factor and CREB as targets of cytokine signaling.
Patricia Mora-Garcia, Jerry Cheng, Heather N Crans-Vargas, Athena Countouriotis, Deepa Shankar

Stem Cells· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface antigen and molecular targeting in the treatment of hematologic malignancies.
Athena Countouriotis, Theodore B Moore, Kathleen M Sakamoto

Stem Cells· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis